Showing results (261-270 of 537) with videos related to

Sort By:
Pageof 54
Acta Oncologica (Stockholm, Sweden)|September 18, 2014
A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancerThomas P Kole, R Charles Nichols, Song Lei, et al.
Frontiers in Oncology|June 5, 2013
Frameless fractionated stereotactic radiosurgery for vestibular schwannomas: a single-institution experienceSana D Karam, Alexander Tai, Alexis Strohl, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|March 29, 2020
Myocardial Infarction Can Be Safely Excluded by High-sensitivity Troponin I Testing 3 Hours After Emergency Department PresentationW Frank Peacock, Robert Christenson, Deborah B Diercks, et al.
Frontiers in Oncology|February 11, 2020
Self-Reported Burden in Elderly Patients With Localized Prostate Cancer Treated With Stereotactic Body Radiation Therapy (SBRT)Nima Aghdam, Abigail Pepin, Michael Carrasquilla, et al.
Frontiers in Oncology|July 21, 2015
Dysuria Following Stereotactic Body Radiation Therapy for Prostate CancerEinsley-Marie Janowski, Thomas P Kole, Leonard N Chen, et al.
International Journal of Particle Therapy|July 1, 2022
Prostate Cancer Treatment with Pencil Beam Proton Therapy Using Rectal Spacers sans Endorectal BalloonsMatthew Forsthoefel, Ryan Hankins, Elizabeth Ballew, et al.
JAMA Cardiology|October 20, 2017
Incorporating Patient and Caregiver Experiences Into Cardiovascular Clinical Trial DesignSean P Collins, Phillip D Levy, Jane L Holl, et al.
Frontiers in Oncology|August 27, 2024
The impact of neoadjuvant relugolix on multi-dimensional patient-reported fatigueJessica Y Hsueh, Lindsey Gallagher, Min Ji Koh, et al.
Frontiers in Oncology|January 11, 2021
Stereotactic Body Radiation Therapy: A Versatile, Well-Tolerated, and Effective Treatment Option for Extracranial Metastases From Primary Ovarian and Uterine CancerNima Aghdam, Michael C Repka, Mary McGunigal, et al.
Frontiers in Oncology|December 16, 2021
Lobar Gross Endobronchial Disease Predicts for Overall Survival and Grade 5 Pulmonary Toxicity in Medically Inoperable Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation TherapyNima Aghdam, Jonathan W Lischalk, Monica Pernia Marin, et al.
Pageof 54